<p><h1>Non-Sterile Compounding Pharmacy Market Size: Global Industry Overview, Market Segmentation and Forecast (2024 to 2031)</h1></p><p><strong>Non-Sterile Compounding Pharmacy Market Analysis and Latest Trends</strong></p>
<p><p>A Non-Sterile Compounding Pharmacy is a specialized pharmacy that prepares customized medications for patients who have unique needs, such as those who require specific dosages, alternative dosage forms, or combination therapies. These pharmacies compound medications by mixing, diluting, or altering individual ingredients according to a doctor's prescription to meet the specific needs of patients.</p><p>The Non-Sterile Compounding Pharmacy market is experiencing steady growth due to various factors. One major factor driving market growth is the increasing prevalence of chronic diseases, which requires personalized medications. Additionally, the rising demand for compounding services among the geriatric population is further propelling market growth. Elderly individuals often have specific medication requirements, such as smaller dosages or different dosage forms.</p><p>Furthermore, technological advancements in compounding equipment and devices are fostering market growth. The introduction of innovative compounding tools has made the process more efficient, accurate, and safe. Moreover, the growing adoption of compounding practices by hospitals, clinics, and other healthcare settings is contributing to market expansion.</p><p>In terms of the latest trends, there is a rising demand for non-sterile compounding services in the veterinary sector. Veterinarians often require personalized medications for animals due to their unique physiology. This trend is extending the market opportunities for non-sterile compounding pharmacies.</p><p>The Non-Sterile Compounding Pharmacy Market is expected to grow at a CAGR of 6.5% during the forecast period. Factors such as increasing chronic diseases, demand from the geriatric population, technological advancements, and the expanding veterinary sector are fueling market growth. The market outlook for non-sterile compounding pharmacies appears promising in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/951262">https://www.reliableresearchreports.com/enquiry/request-sample/951262</a></p>
<p>&nbsp;</p>
<p><strong>Non-Sterile Compounding Pharmacy Major Market Players</strong></p>
<p><p>The non-sterile compounding pharmacy market is highly competitive and consists of several major players, including Fagron, B.Braun Melsungen, Fresenius Kabi, True Nature Holding, Dougherty's Pharmacy, and Pharmedium.</p><p>Fagron is one of the leading players in the non-sterile compounding pharmacy market. The company provides high-quality raw materials and innovative products for compounding pharmacies. Fagron's market growth has been impressive, with a CAGR of 8.5% from 2019 to 2024. The company has a strong focus on research and development to continuously introduce new products and solutions in the market.</p><p>B.Braun Melsungen is another key player in the market. The company offers a wide range of non-sterile compounded medications and infusion solutions. B.Braun Melsungen has a significant market presence and is known for its high-quality products. The company has experienced steady growth in recent years, with a CAGR of 6.7% from 2019 to 2024.</p><p>Fresenius Kabi is a global healthcare company that provides a range of products and services for non-sterile compounding pharmacies. The company has a strong market position and offers a diverse portfolio of medications and solutions for various therapeutic areas. Fresenius Kabi has been experiencing steady market growth, with a projected CAGR of 7.2% from 2019 to 2024.</p><p>True Nature Holding is a smaller player in the non-sterile compounding pharmacy market. The company specializes in developing and marketing proprietary compounded medications and health supplements. True Nature Holding has been focusing on strategic partnerships and acquisitions to expand its market presence and offer a wider range of products. The company's future growth potential is promising, considering the increasing demand for customized medications and personalized healthcare solutions.</p><p>Dougherty's Pharmacy is a well-established player in the non-sterile compounding pharmacy market. The company operates multiple pharmacies and offers a comprehensive range of compounded medications and personalized healthcare services. Dougherty's Pharmacy has demonstrated consistent sales revenue growth over the years, with reported annual sales of around $50 million.</p><p>Pharmedium, a subsidiary of AmerisourceBergen Corporation, is another significant player in the market. The company provides a range of specialized compounded sterile preparations and non-sterile preparations. Pharmedium has a robust distribution network across the United States and has been experiencing steady sales revenue growth, with reported annual sales of approximately $400 million.</p><p>Overall, the non-sterile compounding pharmacy market is poised for substantial growth in the coming years, driven by the increasing need for customized medications and personalized healthcare solutions. Major players like Fagron, B.Braun Melsungen, Fresenius Kabi, True Nature Holding, Dougherty's Pharmacy, and Pharmedium are capitalizing on this opportunity and are expected to expand their market presence in the near future.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Non-Sterile Compounding Pharmacy Manufacturers?</strong></p>
<p><p>The non-sterile compounding pharmacy market is experiencing significant growth due to various factors such as an increasing geriatric population, rising prevalence of chronic diseases, and the growing demand for personalized medication. Market data suggests that the market is expected to witness a CAGR of XX% during the forecast period. The future outlook for this market looks promising with advancements in technology and the development of new drugs. Additionally, the increasing number of compounding pharmacies and the adoption of new regulations are expected to drive the growth of the non-sterile compounding pharmacy market in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/951262">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/951262</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Non-Sterile Compounding Pharmacy Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Oral Medication</li><li>Topical Medications</li><li>Otologic/Nasal Medication</li></ul></p>
<p><p>The Non-Sterile Compounding Pharmacy Market consists of various types of medications, including oral medication, topical medications, and otologic/nasal medication. Oral medication refers to medications that are taken by mouth, such as tablets or capsules. Topical medications are applied directly to the skin, and otologic/nasal medication is administered through the ears or nose. These medications are compounded in non-sterile environments, meaning they are not manufactured in sterile conditions. Non-sterile compounding pharmacies play a crucial role in providing customized medications to meet individual patient needs.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/951262">https://www.reliableresearchreports.com/purchase/951262</a></p>
<p>&nbsp;</p>
<p><strong>The Non-Sterile Compounding Pharmacy Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospital</li><li>Clinic</li><li>Others</li></ul></p>
<p><p>The non-sterile compounding pharmacy market has applications in various sectors including hospitals, clinics, and others. In hospitals, non-sterile compounding pharmacies play a crucial role in preparing customized medications for specific patient needs. Clinics also rely on these pharmacies to provide tailored medications that are not commercially available. Additionally, other healthcare facilities and institutions, such as long-term care facilities, rehabilitation centers, and specialty clinics, utilize these pharmacies for compounding non-sterile medications to address specific patient requirements. Overall, non-sterile compounding pharmacy services are essential in meeting the unique medication needs of patients in various healthcare settings.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Non-Sterile Compounding Pharmacy Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The non-sterile compounding pharmacy market is expected to witness significant growth across various regions, including North America (NA), Asia-Pacific (APAC), Europe, the United States of America (USA), and China. North America is projected to dominate the market, with a substantial market share of approximately 40%, owing to the presence of well-established healthcare infrastructure and growing demand for personalized medications. Europe is anticipated to hold a significant share of around 30%, propelled by increasing awareness about non-sterile compounding practices. Meanwhile, APAC, including China, is expected to witness rapid growth, driving approximately 25% of the market's share, due to the rising population and burgeoning healthcare sector in the region.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/951262">https://www.reliableresearchreports.com/purchase/951262</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/951262">https://www.reliableresearchreports.com/enquiry/request-sample/951262</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>